These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 36509367)

  • 1. The Cost-Effectiveness of Financial Incentives to Achieve Heroin Abstinence in Individuals With Heroin Use Disorder Starting New Treatment Episodes: A Cluster Randomized Trial-Based Economic Evaluation.
    Shearer J; Metrebian N; Weaver T; Goldsmith K; Strang J; Pilling S; Mitcheson L; Day E; Dunn J; Glasper A; Akhtar S; Bajaria J; Charles V; Desai R; Haque F; Little N; McKechnie H; Mosler F; Mutz J; Poovendran D; Byford S
    Value Health; 2023 May; 26(5):658-665. PubMed ID: 36509367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using a pragmatically adapted, low-cost contingency management intervention to promote heroin abstinence in individuals undergoing treatment for heroin use disorder in UK drug services (PRAISE): a cluster randomised trial.
    Metrebian N; Weaver T; Goldsmith K; Pilling S; Hellier J; Pickles A; Shearer J; Byford S; Mitcheson L; Bijral P; Bogdan N; Bowden-Jones O; Day E; Dunn J; Glasper A; Finch E; Forshall S; Akhtar S; Bajaria J; Bennett C; Bishop E; Charles V; Davey C; Desai R; Goodfellow C; Haque F; Little N; McKechnie H; Mosler F; Morris J; Mutz J; Pauli R; Poovendran D; Phillips E; Strang J;
    BMJ Open; 2021 Jul; 11(7):e046371. PubMed ID: 34210725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive reinforcement targeting abstinence in substance misuse (PRAISe): Study protocol for a Cluster RCT & process evaluation of contingency management.
    Metrebian N; Weaver T; Pilling S; Hellier J; Byford S; Shearer J; Mitcheson L; Astbury M; Bijral P; Bogdan N; Bowden-Jones O; Day E; Dunn J; Finch E; Forshall S; Glasper A; Morse G; Akhtar S; Bajaria J; Bennett C; Bishop E; Charles V; Davey C; Desai R; Goodfellow C; Haque F; Little N; McKechnie H; Morris J; Mosler F; Mutz J; Pauli R; Poovendran D; Slater E; Strang J
    Contemp Clin Trials; 2018 Aug; 71():124-132. PubMed ID: 29908336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of incentives for naltrexone adherence on opiate abstinence in heroin-dependent adults.
    Jarvis BP; Holtyn AF; DeFulio A; Dunn KE; Everly JJ; Leoutsakos JS; Umbricht A; Fingerhood M; Bigelow GE; Silverman K
    Addiction; 2017 May; 112(5):830-837. PubMed ID: 27936293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-engineering methadone-Cost-effectiveness analysis of a patient-centered approach to methadone treatment.
    Dunlap LJ; Zarkin GA; Orme S; Meinhofer A; Kelly SM; O'Grady KE; Gryczynski J; Mitchell SG; Schwartz RP
    J Subst Abuse Treat; 2018 Nov; 94():81-90. PubMed ID: 30243422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of contingency management incentives to improve completion of hepatitis B vaccination in people undergoing treatment for heroin dependence: a cluster randomised trial.
    Weaver T; Metrebian N; Hellier J; Pilling S; Charles V; Little N; Poovendran D; Mitcheson L; Ryan F; Bowden-Jones O; Dunn J; Glasper A; Finch E; Strang J
    Lancet; 2014 Jul; 384(9938):153-63. PubMed ID: 24725468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and cost-effectiveness of unsupervised buprenorphine-naloxone for the treatment of heroin dependence in a randomized waitlist controlled trial.
    Dunlop AJ; Brown AL; Oldmeadow C; Harris A; Gill A; Sadler C; Ribbons K; Attia J; Barker D; Ghijben P; Hinman J; Jackson M; Bell J; Lintzeris N
    Drug Alcohol Depend; 2017 May; 174():181-191. PubMed ID: 28371689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A contingency management intervention to reduce cannabis use and time to relapse in early psychosis: the CIRCLE RCT.
    Johnson S; Rains LS; Marwaha S; Strang J; Craig T; Weaver T; McCrone P; King M; Fowler D; Pilling S; Marston L; Omar RZ; Craig M; Spencer J; Hinton M
    Health Technol Assess; 2019 Aug; 23(45):1-108. PubMed ID: 31460865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and cost-effectiveness of an adjunctive personalised psychosocial intervention in treatment-resistant maintenance opioid agonist therapy: a pragmatic, open-label, randomised controlled trial.
    Marsden J; Stillwell G; James K; Shearer J; Byford S; Hellier J; Kelleher M; Kelly J; Murphy C; Mitcheson L
    Lancet Psychiatry; 2019 May; 6(5):391-402. PubMed ID: 30952568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.
    Connock M; Juarez-Garcia A; Jowett S; Frew E; Liu Z; Taylor RJ; Fry-Smith A; Day E; Lintzeris N; Roberts T; Burls A; Taylor RS
    Health Technol Assess; 2007 Mar; 11(9):1-171, iii-iv. PubMed ID: 17313907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of cocaine contingency management in heroin-assisted treatment: Results of a randomized controlled trial.
    Blanken P; Hendriks VM; Huijsman IA; van Ree JM; van den Brink W
    Drug Alcohol Depend; 2016 Jul; 164():55-63. PubMed ID: 27177805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness of prize-based and voucher-based contingency management in a population of cocaine- or opioid-dependent outpatients.
    Olmstead TA; Petry NM
    Drug Alcohol Depend; 2009 Jun; 102(1-3):108-15. PubMed ID: 19324501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bupropion Slow Release vs Placebo With Adaptive Incentives for Cocaine Use Disorder in Persons Receiving Methadone for Opioid Use Disorder: A Randomized Clinical Trial.
    Ware OD; Sweeney MM; Cunningham C; Umbricht A; Stitzer M; Dunn KE
    JAMA Netw Open; 2023 Mar; 6(3):e232278. PubMed ID: 36920397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An economic evaluation of contingency management for completion of hepatitis B vaccination in those on treatment for opiate dependence.
    Rafia R; Dodd PJ; Brennan A; Meier PS; Hope VD; Ncube F; Byford S; Tie H; Metrebian N; Hellier J; Weaver T; Strang J
    Addiction; 2016 Sep; 111(9):1616-27. PubMed ID: 26990598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence.
    Bell J; Shanahan M; Mutch C; Rea F; Ryan A; Batey R; Dunlop A; Winstock A
    Addiction; 2007 Dec; 102(12):1899-907. PubMed ID: 17784896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting.
    Harris AH; Gospodarevskaya E; Ritter AJ
    Pharmacoeconomics; 2005; 23(1):77-91. PubMed ID: 15693730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction.
    Byford S; Barrett B; Metrebian N; Groshkova T; Cary M; Charles V; Lintzeris N; Strang J
    Br J Psychiatry; 2013 Nov; 203(5):341-9. PubMed ID: 24029536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of buprenorphine and naltrexone treatments for heroin dependence in Malaysia.
    Ruger JP; Chawarski M; Mazlan M; Ng N; Schottenfeld R
    PLoS One; 2012; 7(12):e50673. PubMed ID: 23226534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Financial incentives to promote extended smoking abstinence in opioid-maintained patients: a randomized trial.
    Sigmon SC; Miller ME; Meyer AC; Saulsgiver K; Badger GJ; Heil SH; Higgins ST
    Addiction; 2016 May; 111(5):903-12. PubMed ID: 26638126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.